NASDAQ:BSPM - Biostar Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.46 -0.06 (-2.38 %)
(As of 05/22/2018 06:00 AM ET)
Previous Close$2.46
Today's Range$2.46 - $2.58
52-Week Range$1.18 - $5.97
Volume47,810 shs
Average Volume329,741 shs
Market Capitalization$6.64 million
P/E Ratio3.60
Dividend YieldN/A
Beta2.3

About Biostar Pharmaceuticals (NASDAQ:BSPM)

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Receive BSPM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BSPM
CUSIPN/A
Phone011-86-29-3368-6638

Debt

Debt-to-Equity RatioN/A
Current Ratio0.19
Quick Ratio0.16

Price-To-Earnings

Trailing P/E Ratio3.60
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.38 million
Price / Sales2.73
Cash FlowN/A
Price / CashN/A
Book Value$13.98 per share
Price / Book0.18

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-5,690,000.00
Net MarginsN/A
Return on Equity2.59%
Return on Assets2.25%

Miscellaneous

Employees200
Outstanding Shares2,640,000

Biostar Pharmaceuticals (NASDAQ:BSPM) Frequently Asked Questions

What is Biostar Pharmaceuticals' stock symbol?

Biostar Pharmaceuticals trades on the NASDAQ under the ticker symbol "BSPM."

How were Biostar Pharmaceuticals' earnings last quarter?

Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) issued its quarterly earnings results on Wednesday, November, 15th. The company reported ($0.50) earnings per share (EPS) for the quarter. During the same period last year, the business posted ($3.12) EPS. View Biostar Pharmaceuticals' Earnings History.

Who are some of Biostar Pharmaceuticals' key competitors?

Who are Biostar Pharmaceuticals' key executives?

Biostar Pharmaceuticals' management team includes the folowing people:
  • Mr. Ronghua Wang, Chairman, CEO & Pres (Age 62)
  • Mr. Zhenghong Wang, Chief Operating Officer (Age 38)
  • Ms. Xiaojuan Zhai, Chief Financial Officer (Age 29)
  • Prof. Xiaohui Zheng, Chief Scientist (Age 50)
  • Ms. Shuang Gong, Director of Admin. & Sec. of Board (Age 51)

Has Biostar Pharmaceuticals been receiving favorable news coverage?

Media headlines about BSPM stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Biostar Pharmaceuticals earned a daily sentiment score of 0.14 on Accern's scale. They also assigned press coverage about the company an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Biostar Pharmaceuticals?

Shares of BSPM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biostar Pharmaceuticals' stock price today?

One share of BSPM stock can currently be purchased for approximately $2.46.

How big of a company is Biostar Pharmaceuticals?

Biostar Pharmaceuticals has a market capitalization of $6.64 million and generates $2.38 million in revenue each year. Biostar Pharmaceuticals employs 200 workers across the globe.

How can I contact Biostar Pharmaceuticals?

Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG SHAANXI PROVINCE F4, 712046. The company can be reached via phone at 011-86-29-3368-6638.


MarketBeat Community Rating for Biostar Pharmaceuticals (BSPM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about Biostar Pharmaceuticals and other stocks. Vote "Outperform" if you believe BSPM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSPM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Biostar Pharmaceuticals (NASDAQ:BSPM) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/22/2016 forward)

Earnings

Biostar Pharmaceuticals (NASDAQ:BSPM) Earnings History and Estimates Chart

Earnings by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Biostar Pharmaceuticals (NASDAQ BSPM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017Q3 17($0.50)ViewN/AView Earnings Details
5/19/2017Q1 2017($0.38)ViewN/AView Earnings Details
4/13/2017Q4 2016$1.63$0.32 millionViewN/AView Earnings Details
11/21/2016Q3 16($0.71)$0.65 millionViewN/AView Earnings Details
8/22/2016Q2($3.12)$0.62 millionViewN/AView Earnings Details
5/23/2016Q1($0.28)$0.80 millionViewN/AView Earnings Details
11/23/2015Q3 15($0.08)$4.21 millionViewN/AView Earnings Details
8/19/2015Q215($0.03)$19.20 million$14.20 millionViewN/AView Earnings Details
5/15/2015Q1 15($0.01)$6.91 millionViewN/AView Earnings Details
4/15/2015Q4 2014$1.26$14.39 millionViewN/AView Earnings Details
11/14/2014Q3 2014$0.14$14.65 millionViewN/AView Earnings Details
8/14/2014Q2 2014$0.77$19.20 millionViewN/AView Earnings Details
5/15/2014Q1 2014$0.14$13.18 millionViewN/AView Earnings Details
3/31/2014Q4 2013$0.28$10.98 millionViewN/AView Earnings Details
11/14/2013Q3 2013$0.21$15.01 millionViewN/AView Earnings Details
8/19/2013Q2 2013($0.06)$8.20 million$14.70 millionViewN/AView Earnings Details
5/16/2013Q1 2013$0.42$12.09 millionViewN/AView Earnings Details
4/15/2013Q4 2012($4.76)ViewN/AView Earnings Details
11/19/2012Q312($0.63)$24.78 million$9.97 millionViewN/AView Earnings Details
8/14/2012Q2 2012($2.66)ViewN/AView Earnings Details
5/15/2012Q1 2012$2.20ViewN/AView Earnings Details
3/27/2012Q4 2011$1.72ViewN/AView Earnings Details
11/14/2011Q3 2011$3.32ViewN/AView Earnings Details
8/15/2011Q2 2011$3.13ViewN/AView Earnings Details
5/16/2011Q1 2011$2.52$2.08ViewN/AView Earnings Details
3/25/2011Q4 2010$4.62$4.62ViewN/AView Earnings Details
11/15/2010Q3 2010$2.62ViewN/AView Earnings Details
8/17/2010Q2 2010$4.22ViewN/AView Earnings Details
5/17/2010Q1 2010$1.74ViewN/AView Earnings Details
4/1/2010Q4 2009($0.92)ViewN/AView Earnings Details
11/12/2009Q3 2009$2.77ViewN/AView Earnings Details
8/14/2009Q2 2009$3.57ViewN/AView Earnings Details
5/14/2009Q1 2009$1.64ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Biostar Pharmaceuticals (NASDAQ:BSPM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Biostar Pharmaceuticals (NASDAQ BSPM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 17.20%
Institutional Ownership Percentage: 4.02%
Insider Trading History for Biostar Pharmaceuticals (NASDAQ:BSPM)

Biostar Pharmaceuticals (NASDAQ BSPM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Biostar Pharmaceuticals (NASDAQ BSPM) News Headlines

Source:
DateHeadline
Who Are The Major Shareholders Of Biostar Pharmaceuticals Inc (NASDAQ:BSPM)?Who Are The Major Shareholders Of Biostar Pharmaceuticals Inc (NASDAQ:BSPM)?
finance.yahoo.com - April 10 at 5:22 PM
Biostar Pharmaceuticals (BSPM) to Release Quarterly Earnings on WednesdayBiostar Pharmaceuticals (BSPM) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 4 at 1:12 AM
Is Biostar Pharmaceuticals Inc (NASDAQ:BSPM) A Financially Sound Company?Is Biostar Pharmaceuticals Inc (NASDAQ:BSPM) A Financially Sound Company?
finance.yahoo.com - March 9 at 9:55 AM
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP CertificationShaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
finance.yahoo.com - February 8 at 7:01 AM
Biostar Pharma Post Huge Gains, Pipeline Review, and a New ProductBiostar Pharma Post Huge Gains, Pipeline Review, and a New Product
finance.yahoo.com - February 1 at 3:28 PM
Why Biostar Pharmaceuticals Inc (NASDAQ:BSPM) May Not Be As Efficient As Its IndustryWhy Biostar Pharmaceuticals Inc (NASDAQ:BSPM) May Not Be As Efficient As Its Industry
finance.yahoo.com - January 29 at 7:24 AM
December Undervalued Opportunities – Biostar Pharmaceuticals And MoreDecember Undervalued Opportunities – Biostar Pharmaceuticals And More
finance.yahoo.com - December 29 at 10:24 AM
Biostar Pharma (BSPM) Reports Compliance with NASDAQ Continued Listing RequirementBiostar Pharma (BSPM) Reports Compliance with NASDAQ Continued Listing Requirement
www.streetinsider.com - December 5 at 10:42 AM
Biostar Regains Compliance with NASDAQ Continued Listing RequirementBiostar Regains Compliance with NASDAQ Continued Listing Requirement
finance.yahoo.com - December 4 at 4:53 PM
Network-1 Technologies And Other Top Undervalued StocksNetwork-1 Technologies And Other Top Undervalued Stocks
finance.yahoo.com - November 24 at 11:24 AM
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
www.prnewswire.com - November 20 at 4:23 PM
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017
finance.yahoo.com - November 16 at 12:12 PM
Biostar Pharmaceuticals, Inc. (BSPM) Releases  Earnings ResultsBiostar Pharmaceuticals, Inc. (BSPM) Releases Earnings Results
www.americanbankingnews.com - November 16 at 10:14 AM
Is Biostar Pharmaceuticals Inc’s (BSPM) Balance Sheet Strong Enough To Weather A Storm?Is Biostar Pharmaceuticals Inc’s (BSPM) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - November 3 at 10:28 PM
3 Trending Biotech Stocks To Watch On Monday3 Trending Biotech Stocks To Watch On Monday
finance.yahoo.com - October 9 at 5:32 PM
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency NoticeBiostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency NoticeBiostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) Scheduled to Post Earnings on MondayBiostar Pharmaceuticals, Inc. (NASDAQ:BSPM) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - August 14 at 1:46 AM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q1 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q1 Earnings Report
www.rttnews.com - May 21 at 11:26 AM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing RuleBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
biz.yahoo.com - February 24 at 9:13 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - February 9 at 9:18 PM
Drug Makers Stocks on Investors Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron TherapeuticsDrug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron Therapeutics
www.bizjournals.com - January 3 at 10:00 AM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q3 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q3 Earnings Report
www.rttnews.com - November 22 at 3:30 PM
Biostar Pharmaceuticals Inc. (BSPM) Is Spiking To The UpsideBiostar Pharmaceuticals Inc. (BSPM) Is Spiking To The Upside
www.rttnews.com - October 18 at 3:56 PM
Biostar Pharma (BSPM) Enters 425k Share Securities Purchase AgreementBiostar Pharma (BSPM) Enters 425k Share Securities Purchase Agreement
www.streetinsider.com - October 13 at 10:20 AM
Biostar Announces Execution of Agreement for $1.91 Million Registered Direct ...Biostar Announces Execution of Agreement for $1.91 Million Registered Direct ...
www.prnewswire.com - October 12 at 4:13 PM
Biostar Pharma (BSPM) Announces Launch of Easy Breathing Product; Will Target Rhinitis, SinusitisBiostar Pharma (BSPM) Announces Launch of 'Easy Breathing' Product; Will Target Rhinitis, Sinusitis
www.streetinsider.com - October 12 at 8:27 AM
Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and SinusitisBiostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
www.prnewswire.com - October 12 at 8:27 AM
It was a bad day for stocks, but these three delivered good newsIt was a bad day for stocks, but these three delivered good news
investorplace.com - October 12 at 8:27 AM
Biostar Pharmaceuticals Inc. (BSPM) Surged After New Product AnnouncementBiostar Pharmaceuticals Inc. (BSPM) Surged After New Product Announcement
www.rttnews.com - October 12 at 8:27 AM
Biostar Pharma Skyrockets on New Chinese Product LaunchBiostar Pharma Skyrockets on New Chinese Product Launch
247wallst.com - October 11 at 3:46 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - September 23 at 9:05 AM
Biostar Pharma (BSPM) Signs LOI to Acquire Xianyang Yongsheng Health ProductsBiostar Pharma (BSPM) Signs LOI to Acquire Xianyang Yongsheng Health Products
www.streetinsider.com - September 22 at 4:07 PM
Biostar Pharmaceuticals Inc. (BSPM) Is Up Sharply In Early TradeBiostar Pharmaceuticals Inc. (BSPM) Is Up Sharply In Early Trade
www.rttnews.com - September 21 at 8:31 AM
Mid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 ExpectationsMid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 Expectations
www.benzinga.com - August 23 at 4:03 PM
EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q2 Earnings ReportEARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q2 Earnings Report
www.rttnews.com - August 23 at 4:02 PM
BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersBIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 13 at 5:02 PM
Biostar Pharmaceuticals Inc. (BSPM) Has Jumped To Nearly A 2-Month HighBiostar Pharmaceuticals Inc. (BSPM) Has Jumped To Nearly A 2-Month High
www.rttnews.com - June 8 at 4:29 PM

SEC Filings

Biostar Pharmaceuticals (NASDAQ:BSPM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Biostar Pharmaceuticals (NASDAQ:BSPM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Biostar Pharmaceuticals (NASDAQ BSPM) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.